The SPECT-CT Scanners industry trends over the past 18 months reflect accelerated innovation driven by partnerships and regulatory shifts. Notably, GE HealthCare and Siemens Healthineers expanded their hybrid imaging portfolios through strategic acquisitions, including Siemens’ 2023 purchase of a AI-driven radiology startup to enhance SPECT-CT image analysis. Meanwhile, United Imaging launched its uCT Elite series, integrating SPECT-CT with advanced AI algorithms for real-time cardiac diagnostics, capturing significant market traction in Asia-Pacific. Regulatory updates, such as the FDA’s 2024 clearance for compact SPECT-CT systems, have spurred demand in ambulatory care settings, aligning with healthcare providers’ push for decentralized imaging solutions. Funding activity surged, with Liferay Health securing $45M in Series B financing to scale its portable SPECT-CT technology, addressing rural healthcare gaps. Enterprise trends also highlight a shift toward hybrid systems combining SPECT-CT with PET imaging, driven by rising oncology and cardiology applications. These developments underscore the sector’s pivot toward AI integration, miniaturization, and regulatory adaptability to meet evolving diagnostic demands.
